lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Caution: Clinical Characteristics of COVID-19 Patients Are Changing at Admission

9 Pages Posted: 2 Mar 2020

See all articles by Zhaowei Chen

Zhaowei Chen

Wuhan University - Division of Nephrology

Jijia Hu

Wuhan University - Division of Nephrology

Zongwei Zhang

Wuhan University - Department of Nephrology

Shan Jiang

Wuhan University - Department of Dermatology

Tao Wang

Wuhan University - Department II of Respiratory Disease and Intensive Care

Zhengli Shi

Chinese Academy of Sciences (CAS) - Key Laboratory of Special Pathogens and Biosafety

Zhan Zhang

Wuhan University - Department of Nephrology

More...

Abstract

Background: With the emergence of the 4th generation transmission, the prevention and treatment of the novel coronavirus disease 2019 (COVID-19) has entered a new period. During the admission, we found several changes in the clinical characteristics of patients with COVID-19.

Methods: Patients suffered from COVID-19 were diagnosed and admitted to Renmin Hospital of Wuhan University. Clinical records, laboratory results were retrospectively reviewed and matched with the admission date to analyze characteristic changes of patients at the onset of illness.

Findings: From Jan. 16 to Jan. 29, 2020, 89 patients had been identified as confirmed COVID-19. Patients were assigned into two groups according to the admission date. 31 [34·8%] of the infected patients were admitted from Jan. 16 to 22, and 58 [65·2%] were admitted from Jan. 23 to 29. Most of the infected patients were women (45 [77·6%] of 58) during Jan. 23 to 29, but less female (14 [45·2%] of 31) before Jan. 23. Patients admitted with more systemic symptoms such as fever (21 [67·7%] of 31), fatigue (13 [41·9%] of 31), and myalgia (7 [22·6%] of 31) before Jan. 23. Greater proportion of patients (10 [32·3%] of 31) admitted before Jan. 23 had a small amount of sputum production compared with a small proportion (4 [6·9%] of 58) admitted after Jan. 23. Other symptoms such as cough, nausea, diarrhea, and chest tightness were not significantly different between two groups. In addition, the group admitted before Jan. 23 had a larger proportion of patients with reduced lymphocyte (13 [54·2%] of 24), CD3 (11[52·4%] of 21), CD8 (9 [42·9%] of 21) cells and elevated SAA (18 [75·0%] of 24).

Interpretation: The clinical characteristics of COVID-19 patients at the onset became partially different as the novel coronavirus spreads over time and generations, positive infection even appeared in patients after discharge. Findings from this study suggest that initial symptoms of recently infected patients seem more insidious. All provide clues that the new coronavirus may gradually evolve into an influenza-like virus, or it may be latent in some asymptomatic carrier for a long time.

Funding Statement: No funding supported this study.

Declaration of Interests: All the authors declare no competing interests.

Ethics Approval Statement: The research protocol was reviewed and approved by the Ethics Committee in Renmin Hospital of Wuhan University (Wuhan, China). All research procedures adhered to the tenets of the Declaration of Helsinki.

Keywords: COVID-19; SARS-CoV-2; Admission characteristics

Suggested Citation

Chen, Zhaowei and Hu, Jijia and Zhang, Zongwei and Jiang, Shan and Wang, Tao and Shi, Zhengli and Zhang, Zhan, Caution: Clinical Characteristics of COVID-19 Patients Are Changing at Admission (February 24, 2020). Available at SSRN: https://ssrn.com/abstract=3546044 or http://dx.doi.org/10.2139/ssrn.3546044

Zhaowei Chen

Wuhan University - Division of Nephrology

China

Jijia Hu

Wuhan University - Division of Nephrology

China

Zongwei Zhang

Wuhan University - Department of Nephrology

Wuhan
China

Shan Jiang

Wuhan University - Department of Dermatology

China

Tao Wang

Wuhan University - Department II of Respiratory Disease and Intensive Care

China

Zhengli Shi

Chinese Academy of Sciences (CAS) - Key Laboratory of Special Pathogens and Biosafety

China

Zhan Zhang (Contact Author)

Wuhan University - Department of Nephrology ( email )

Wuhan
China